Cryoablation of Small Renal Tumors in Patients with Solitary Kidneys: Initial Experience
Advances in Urology · 2008
DOI: 10.1155/2008/197324 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Urology, 2008. Verfasst von Ravi Munver und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Hackensack University Medical Center, 360 Essex Street, Suite 403, Hackensack, NJ 07601, USA. rmunver@humed.com. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Introduction
The purpose of this study was to evaluate the role of renal cryoablation in patients with solitary kidneys with the goals of tumor destruction and maximal renal parenchymal preservation.
Methods
Eleven patients with single tumors were treated with cryoablation, of which 10 patients had solitary kidneys and 1 had a nonfunctioning contralateral kidney. All procedures were performed via an open extraperitoneal approach; ten tumors were treated with in-situ cryoablation and 1 tumor was treated with cryo-assisted partial nephrectomy.
Results
Cryoablation was successfully performed without any preoperative complications. Mean patient age was 62.4 years (range 49–79), tumor location included: 6 (upper pole), 2 (mid-kidney), 3 (lower pole). The mean and median tumor size was 2.6 cm and 2.8 cm (range 1.2–4.3 cm), mean operative time 205 minutes (range 180–270 minutes), blood loss 98.5 ml (range 40–250 ml), and hospitalization 4.6 days (range 3–8 days). Creatinine values included: preoperative 1.43 mg/dL (range 1.2–1.9), postoperative 1.67 mg/dL (range 1.5–2.5), and nadir 1.57 mg/dL (range 1.3–2.1). All patients were followed postoperatively with magnetic resonance imaging for surveillance. At a median follow-up of 43 months, 9 patients had no evidence of recurrence, 1 patient has an enhancing indeterminate area, and 1 patient was lost to follow-up.
Conclusion
Intermediate-term results suggest that renal cryoablation offers a feasible alternative for patients that require a maximal nephron-sparing effort with preservation of renal function and minimal risk of tumor recurrence.
Autor:innen und Institutionen
- Department of Urology, Hackensack University Medical Center, 360 Essex Street, Suite 403, Hackensack, NJ 07601, USA. rmunver@humed.com
Zitieren
APA
Munver, R., Disick, G. I., Lombardo, S. A., Bargman, V. G., & Sawczuk, I. S. (2008). Cryoablation of Small Renal Tumors in Patients with Solitary Kidneys: Initial Experience. Advances in Urology. https://doi.org/10.1155/2008/197324
Vancouver
Munver R, Disick GI, Lombardo SA, Bargman VG, Sawczuk IS. Cryoablation of Small Renal Tumors in Patients with Solitary Kidneys: Initial Experience. Advances in Urology. 2008. doi:10.1155/2008/197324
BibTeX
@article{Munver2008,
author = {Munver, Ravi and Disick, Grant I S and Lombardo, Salvatore A and Bargman, Vladislav G and Sawczuk, Ihor S},
title = {Cryoablation of Small Renal Tumors in Patients with Solitary Kidneys: Initial Experience},
journal = {Advances in Urology},
year = {2008},
doi = {10.1155/2008/197324}
}
EUVIMED